The US Centers for Medicare and Medicaid Services aims to withdraw the Trump administration's plan for a demonstration project to lower Medicare spending on high-cost Part B drugs by matching reimbursement rates to the lowest price found in certain countries abroad, also known as the "most favored nation" policy.
CMS Scraps ‘Most Favored Nation’ Rule To Lower Medicare Part B Drug Costs
US Centers For Medicare and Medicaid Services doesn’t tip its hand on what, if anything, might replace the rule but says it is exploring ways to lower spending on Medicare Part B drugs.
